Wednesday, October 21, 2026

Palantir's Analyst Upgrades Meet a 7% Slide, While Defense Stocks Get Their Own Warning

Analysts turned more bullish on Palantir in mid-October 2026, and the company announced several partnerships. The shares still fell 7% in one session. J.P. Morgan's defense analyst, meanwhile, downgraded Leidos. Every figure here traces to a named source.

LM Salvado
LM Salvado

October 21, 2026

Source Trace Score12 source documents12 with a live linkVerifiability: Strong
Palantir's Analyst Upgrades Meet a 7% Slide, While Defense Stocks Get Their Own Warning
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.

The share price and the analysts moved in opposite directions

Palantir Technologies shares fell more than 7% on Friday, 16 October 2026, closing at $186.03 after a drop of $14.47. It was the fifth session in a row that the stock finished lower.1 The stock had set a 52-week high of $212.94 earlier the same week.1 The fall came during a broader technology selloff that weighed on the Nasdaq-100 index.1

That is the backdrop to a run of bullish analyst commentary. Optimism about the company's business and the market's mood on the day were pointing in different directions.

What the bulls are actually saying

Bernard Zambonin remains constructive on Palantir. He emphasizes customer expansion and net dollar retention as central to the bull case.1 Net dollar retention measures whether existing customers spend more over time. He also acknowledges that the elevated forward valuation makes continued execution essential.1 In plain terms, the shares are priced for the company to keep delivering.

Ryan Canady upgraded Palantir to Buy. He concluded that customer-built AI applications can remain complementary to Palantir's platforms rather than displace its core offering.1 That addresses a common worry among investors: that clients will build their own AI tools and stop needing Palantir's.

Two further analysts, Fiorillo and Zaccardi, are named in our research as having turned more positive. The source material we hold contains no verified statements from either, so we do not characterize their views.

A run of partnership announcements

Palantir's name also appeared in several announcements within a few days:

  • On 13 October 2026, Ondas and Palantir announced Regna AI. It is a standalone private company meant to help governments, businesses and institutions develop and deploy AI models in sovereign environments. Palantir is expected to provide model-training infrastructure and engineering.2
  • On 14 October 2026, Customers Bank announced a collaboration with Palantir to develop an AI-oriented banking operating model. The bank's own forward-looking statements highlight implementation risks, reliability concerns and contractual flexibility.3
  • On 14 October 2026, Surf Air Mobility signed Flying Zebra as its fifth commercial OperatorOS customer. The software is powered by Palantir, and Surf Air receives a percentage of revenue from trips managed through the platform.4

The Customers Bank caveat is worth keeping in mind. The bank's own announcement flags risks alongside the promise. These are announced collaborations, and our records show no results or revenue figures from any of them yet.

The other half of the story: a sour defense tape

The same weeks brought a much less cheerful message from the defense sector. On 8 October 2026, J.P. Morgan's lead aerospace and defense analyst, Seth M. Seifman, described a challenging third-quarter earnings season. He pointed to slowing airline traffic growth, uncertainty over U.S. military spending and lingering supply-chain constraints weighing on investor sentiment.5

His view is nuanced. Most companies, he said, should deliver solid quarterly results and express confidence in underlying demand. But good earnings may not be enough to reverse the sector's stock-market weakness.5 Healthy business and weak share prices can coexist, as Palantir's own session showed.

J.P. Morgan downgraded Leidos. Seifman's reasoning was that the company's relatively low valuation is insufficient to justify an Overweight rating when other aerospace and defense stocks also offer substantial potential returns.5 The downgrade is about relative appeal. It is not a claim that Leidos is in trouble. In the same report he expected Howmet's 2026 earnings estimates to increase and its management to remain confident about growth in aerospace and industrial gas turbines.5

Our records also list BigBear.ai Holdings, Inc. as a competitor of Leidos Holdings, Inc.6 We have no verified figures on how either company is performing against the other.

The election date

The uncertainty over defense spending has a date attached. Congressional midterm elections on 3 November 2026 could change control of Congress and constrain military spending growth. Some of the uncertainty may dissipate after that date.7

How much weight to put on the sources

Both the Palantir and Leidos articles come from NewsEOD. Our measured reliability for that source is 58%: of 927 claims we checked, 58% held up.1,5 That is a middling record. The analyst statements above are reported secondhand through those articles, so treat them as reported views, not independently confirmed facts.

The verified, SEC-sourced data we hold for this story covers Goldman Sachs and contains no Palantir or Leidos financials. We therefore cannot say, from checked numbers, whether Palantir's customer growth or retention is as strong as the bulls argue. We can only report that named analysts say so.

What to watch

  • Palantir's share price after five straight down days. Zambonin ties the bull case to continued execution, and he acknowledges the valuation is high.1
  • Whether the partnerships produce revenue. The announcements describe plans and collaborations, and the Customers Bank statement itself flags implementation risk.3
  • Defense earnings after 3 November. Seifman's warning is that solid results may not lift the shares. The election outcome is the date to watch for the budget question.5,7

This article is analysis of reported information and is not investment advice.

Source documents

Via News is a conduit. We point to the source documents behind this report — we don't replace them. Trace any claim to its source and decide what to trust. How we source

Source Trace Score12 source documents12 with a live linkVerifiability: Strong
  1. [1]News articleYahoo Finance· July 11, 2026
    173-year-old denim giant sees one fashion trend surge 70%
  2. [2]News articleNasdaq· July 3, 2026
    Bull of the Day: Bloom Energy (BE)
  3. [3]News articleSeeking Alpha· July 28, 2026
    D-Wave Quantum dips 10%, moderating previous day's rally
  4. [4]News articleSeeking Alpha· June 24, 2026
    KB Home outlines Q3 2026 housing revenue $1.2B-$1.35B with gross margin 16%-16.6%
  5. [5]News articleSeeking Alpha· October 8, 2026
    Leidos downgraded by J.P. Morgan as defense stocks face rocky earnings season
  6. [6]News articleMotley Fool
    NuScale Power Stock Will Spike 23.7% Over the Next 11 Months According to This Wall Street Analyst
  7. [7]News articleSeeking Alpha· October 16, 2026
    Palantir Technologies declines 7% amid broader tech selloff
  8. [8]News articleMotley Fool
    Why Iovance Biotherapeutics Stock Was on Fire Today
  9. [9]News articleMotley Fool
    Why Wendy's Stock Withered on Wednesday
  10. [10]News articleSeeking Alpha· September 30, 2026
    FactSet expects 5% to 6.5% organic ASV growth in FY '27 while pointing to 25 to 75 bps margin improvement
  11. [11]News articleSeeking Alpha· July 29, 2026
    Landstar outlines July truck revenue per load up about 26% year-over-year while shifting to Q3 commentary over guidance
  12. [12]News articleSeeking Alpha· October 6, 2026
    RPM projects fiscal 2027 mid-single-digit sales and adjusted EBITDA growth as Q2 raw material inflation rises to 9%–11%
LM Salvado
LM Salvado

LM Salvado is an AI possibilist — he takes the risks of AI seriously, and still sees the route through them. Founder of Via News Agency, an AI-native newsroom built on full source-traceability, he tracks how AI is reshaping markets, capital, and labor — the quiet shifts that happen before the headlines catch up.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Crunch: Late-Stage Readouts and Regulatory Milestones Converge on the Ivonescimab PDUFA Date
October 2026 is dense with clinical and regulatory news. Phase 3 trials hit primary endpoints (ALOFT-IPF, RESTORE-3), long-term data came out (MIUDELLA at 6 years, QUILT-3.032), and the FDA accepted Roche's vamikibart BLA. Scholar Rock resubmitted its apitegromab MAA to the EMA. The next catalysts are ESMO 2026 (Oct 23) and the Nov 14 FDA PDUFA date for ivonescimab, followed by Maritime-1 primary completion in January 2027. The speculative QAIAx items (QIII pilot, microcities patent) are a weak, tangential thread with little financial substance.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,406 source documents archived
Query this data → isubstrate.com